Insider Transactions Reported by 17 Insiders of Amylyx Pharmaceuticals, Inc.

Symbol
AMLX on Nasdaq
Location
Cambridge, MA

Insiders trading volume in the past year

Amylyx Pharmaceuticals, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Isaac Cheng Director $170,175,181 09 Jun 2022
ALS Invest 1 B.V. 10%+ Owner $96,258,721 06 Jul 2022
Morningside Venture Investments Ltd 10%+ Owner $81,596,447 15 Aug 2023
Justin B. Klee Co-Chief Executive Officer, Director $49,912,768 -$560,993 -1.1% 30 Sep 2025
Joshua B. Cohen Co-Chief Executive Officer, Director $49,871,891 -$559,608 -1.1% 30 Sep 2025
DRAGSA 96 LLC 10%+ Owner $37,554,630 11 Jan 2022
VIKING GLOBAL INVESTORS LP 10%+ Owner $30,222,333 08 Sep 2022
Margaret Olinger Chief Commercial Officer $5,178,792 27 Dec 2023
JAMES M. FRATES Chief Financial Officer $4,216,602 -$192,456 -4.4% 30 Sep 2025
GEORGE M. MILNE JR Director $3,357,947 05 Jun 2025
Patrick D. Yeramian Chief Medical Officer $3,357,139 09 Jan 2024
Camille L. Bedrosian Chief Medical Officer $2,521,975 -$313,019 -11% 01 Dec 2025
Gina Mazzariello Chief Legal Officer $2,159,169 -$437,778 -17% 30 Sep 2025
Karen Firestone Director $785,595 +$100,845 +15% 23 Dec 2025
Bernhardt G. Zeiher Director $37,005 +$37,005 05 Jun 2025
R. PAUL FONTEYNE Director 05 Jun 2025
Daphne Quimi Director 05 Jun 2025

Recent Insider Transactions by Companies or Individuals for Amylyx Pharmaceuticals, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.